Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Long-Term Deferred Tax (2018 - 2026)

Kamada's (KMDA) quarterly Long-Term Deferred Tax came in at $3.8 million in Q2 2026, up 479.67% on a YoY basis from $659000.0 in Q2 2025, and up 33.29% quarter-over-quarter from $2.9 million in Q1 2026.

Analysis

Kamada (KMDA) Long-Term Deferred Tax (2018 - 2026) Analysis & Trends

Kamada (KMDA) has reported Long-Term Deferred Tax for 6 consecutive years, with $3.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Long-Term Deferred Tax rose 479.67% year-over-year to $3.8 million; the trailing twelve-month figure through Jun 2026 stood at $3.8 million (up 479.67% YoY), and the FY2025 full-year result was $1.7 million, up 238.32% from the prior year.
  • Long-Term Deferred Tax climbed to $3.8 million in Q2 2026 per KMDA's latest filing, from $2.9 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $3.8 million in Q2 2026 and bottomed at $488000.0 in Q4 2024.
  • Historically, Long-Term Deferred Tax has averaged $1.9 million across 3 years, with a median of $1.9 million in 2025.
  • The widest YoY moves for Long-Term Deferred Tax: up 479.67% in 2026, down 39.06% in 2026.
  • Over 3 years, Long-Term Deferred Tax stood at $488000.0 in 2024, then soared by 238.32% to $1.7 million in 2025, then jumped by 131.37% to $3.8 million in 2026.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $3.8 million, $2.9 million, and $1.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.82 Mn
Mar 31, 2026 2.87 Mn
Dec 31, 2025 1.65 Mn
Jun 30, 2025 659,000.00
Mar 31, 2025 2.06 Mn
Dec 31, 2024 488,000.00
Sep 30, 2020 298,000.00
Jun 30, 2020 632,000.00
Mar 31, 2020 939,000.00
Dec 31, 2019 1.31 Mn
Sep 30, 2019 1.45 Mn
Jun 30, 2019 1.64 Mn
Mar 31, 2019 1.90 Mn
Dec 31, 2018 2.05 Mn